TM4SF1 and colorectal carcinoma: Moreover, TM4SF1 siRNA-2 transfection abolished the decrease in cell growth arrest and G2/M phase arrest in B7-H3-overexpressing CRC cells treated with low-dose DOX (Fig. 5D–F).